This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dermtech International. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Thomas Vogt: Innovator in Melanoma Detection
Introduction
Thomas Vogt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of malignant melanoma. His innovative approach focuses on non-invasive methods that enhance the accuracy of melanoma diagnosis.
Latest Patents
Thomas Vogt holds a patent for a method for the detection of melanoma. This invention provides non-invasive techniques for detecting, monitoring, staging, and diagnosing malignant melanoma in skin samples. The methods involve analyzing the expression of various melanoma skin markers, including IL-1 RI, endothelin-2, ephrin-A5, IGF Binding Protein 7, HLA-A0202 heavy chain, Activin A (βA subunit), TNF RII, SPC4, and CNTF Rα. The skin samples can include nucleic acids and may be derived from human lesions suspected of being melanoma.
Career Highlights
Thomas Vogt is associated with Dermtech International, a company that focuses on innovative dermatological solutions. His work at Dermtech International emphasizes the importance of early detection and monitoring of skin cancers, which can significantly improve patient outcomes.
Conclusion
Thomas Vogt's contributions to melanoma detection through his patented methods represent a significant advancement in medical diagnostics. His work continues to pave the way for non-invasive techniques that can enhance the accuracy of skin cancer diagnoses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile